T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford
T-Cypher Bio (“T-Cypher), a biotechnology company developing novel T cell receptor (TCR)-based T cell engagers that target high copy number antigens, today announced its relocation to Abingdon Science Park, Oxford, UK. The new facility at Barton House extends the Company’s footprint to support development of its pipeline of novel immune engager therapeutics targeting areas of…